HKHiroshi Kurosaka

Hiroshi Kurosaka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hiroshi Kurosaka has a total of 254 co-authors. Here are the top co-authors by number of shared publications:

  • Takashi Yamashiro

    Department of Orthodontics and Dentofacial Orthopedics, The University of Osaka Graduate School of Dentistry, Osaka, Japan

    36 shared publications
  • Paul A. Trainor

    Stowers Institute for Medical Research, Kansas City, USA

    13 shared publications
  • Takashi Yamashiro

    Department of Orthodontics and Dentofacial Orthopedics Osaka University Graduate School of Dentistry Suita Japan

    12 shared publications
  • Toshihiro Inubushi

    Department of Orthodontics and Dentofacial Orthopedics, The University of Osaka Graduate School of Dentistry

    12 shared publications
  • Hiroshi Kamioka

    Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

    7 shared publications
  • Takayuki Tsujimoto

    Department of Orthodontics and Dentofacial Orthopedics, The University of Osaka Graduate School of Dentistry

    7 shared publications

Latest Publications

  • Open Access

    A multicentre study on hereditary craniofacial anomalies in orthodontic patients in Japan: clinical characteristics and insurance eligibility

    by Takuya Ogawa, Satoru Hayano, Hiroshi Kamioka, Shinobu Tsuchiya, Kaoru Igarashi, Hiroshi Kurosaka, Takashi Yamashiro, Jun Nihara, Kaori Gunjigake, Tatsuo Kawamoto, et al.

  • Open Access

    Creation and characterization of novel knock-in mouse models of hypophosphatasia

    by Rena Okawa, Marin Ochiai, Hiroshi Kurosaka, Tamami Kadota, Misato Takagi, Yuto Suehiro, Hiroko Okawa, Shuhei Naka, Satoshi Yamaguchi, Shin-Ichi Horike, et al.

    Hypophosphatasia (HPP) is a rare inherited disorder caused by inactivating variants in the ALPL gene, resulting in defective mineralization of bone and teeth. Dental manifestations include early exfoliation of fully rooted primary teeth as a result of cementum dysplasia, premature loss of permanent teeth, and hypomineralization of enamel, dentin, and jawbone. However, genotype-dependent dental phenotypes and severity-based treatment strategies remain poorly defined. The aim of this study was to generate knock-in mouse models harboring clinically relevant ALPL variants and to characterize their dental and periodontal phenotypes in relation to serum tissue-nonspecific alkaline phosphatase (TNAP) activity. We analyzed mice that were compound heterozygous for a null variant and a hypomorphic variant (Alplc.1559delT/p.F327L) and mice that were heterozygous for a dominant-negative variant (Alpl+/p.R184W). Dental and alveolar phenotypes were assessed using micro-CT, histological analyses, and periodontal ligament traction experiments. Alplc.1559delT/p.F327L mice exhibited reduced serum TNAP levels, mild skeletal abnormalities, and severe dental defects, including hypomineralization of enamel, dentin, and cementum, decreased alveolar BMD, and an increased distance from the cemento–enamel junction to the alveolar bone crest. In contrast, Alpl+/p.R184W mice showed isolated dental abnormalities characterized by dentin and cementum hypomineralization and decreased alveolar bone BMD without overt skeletal involvement. Periodontal tissue fragility was increased in both models. These knock-in mouse models recapitulate genotype-dependent dental manifestations of HPP and indicate that dental phenotypes are influenced not only by circulating TNAP levels but also by the functional effects of individual ALPL variants. This platform provides a valuable framework for elucidating the mechanisms underlying genotype-dependent dental manifestations and for developing dental treatment strategies tailored to disease severity.


  • Open Access

    Retinoid signaling promotes frontonasal identity while repressing maxillary identity during craniofacial development

    by Lin Xu, Yanran Wu, Maiko Omi-Sugihara, Dang Yujie, Takayuki Tsujimoto, Qi Wang, Xiuping Nie, Daisuke Motooka, Haruka Ohara, Toshihiro Inubushi, et al.

    Vertebrate facial development depends on the correct specification of embryonic facial prominences, a process known to be governed by region-specific reciprocal signaling pathways between the craniofacial ectoderm and mesenchyme. This process is further modulated by transcriptional and epigenetic mechanisms that regulate the expression of essential genes in mesenchymal progenitors derived from cranial neural crest cells. Retinoid signaling plays a critical role in facial development, and both gain- and loss-of-function results in a wide spectrum of facial defects, including orofacial clefts. In this study, we identified retinoid signaling as a critical regulator of cranial neural crest cell specification toward a frontonasal process identity in mice. Rdh10 oxidizes vitamin A (all-trans retinol) to retinal, which is a rate limiting step in the synthesis of retinoic acid. Rdh10 loss-of-function resulted in ectopic formation of whisker pads - a derivative of maxillary process - within the frontonasal process region. This transformation was evidenced by the mis-expression of maxillary specific transcription factors including Meis2 and Lhx6 in the frontonasal mesenchyme. Furthermore, these transcription factors exhibited increased chromatin accessibility at their consensus binding sites following the loss of retinoid signaling in frontonasal cranial neural crest cells. These results indicate that retinoid signaling acts as a critical regulator specifying frontonasal identity and fate of cranial neural crest cells as they migrate into the frontonasal process, while concomitantly repressing maxillary process fate. These results not only advance our understanding of frontonasal prominence specification and the evolutionary development of craniofacial structures but also offers valuable insights into the etiology and pathogenesis of craniofacial malformations such as orofacial clefts.


  • Open Access

    Synergistic Role of Retinoid and Gata3 Signaling in Olfactory Epithelium Development

    by Ayaka Matsushita, Takayuki Tsujimoto, Nie Xiuping, Maiko Omi‐Sugihara, Lin Xu, Saha Mithun, Shota Natsuyama, Haruka Ohara, Satoshi Koga, Toshihiro Inubushi, et al.

    Craniofacial development requires precise coordination of epithelial patterning and morphogenesis. However, the molecular mechanisms governing olfactory epithelium development remain incompletely understood. Retinoic acid (RA) signaling and Gata3 have each been independently implicated in craniofacial morphogenesis, particularly in the formation of the primitive choanae, which constitute the opening between the nasal cavity and the oral cavity. Here, we generated a tamoxifen‐inducible, genetically controlled compound mutant mouse model to simultaneously disrupt Rdh10 , a rate‐limiting enzyme for RA signaling, and Gata3 during early craniofacial development. We show that while deletion of Rdh10 following tamoxifen administration at E8.5 does not result in obvious craniofacial abnormalities, combined loss of Rdh10 and Gata3 leads to fully penetrant bilateral choanal atresia and severe defects in olfactory epithelium morphogenesis. Immunohistochemical analyses revealed a marked reduction in PAX6 and SIX1 positive cells and a concomitant expansion of SOX2 positive cells in compound mutant embryos. These results demonstrate that RA–Gata3 signaling cooperatively regulates olfactory epithelium development by controlling the balance between progenitor maintenance and lineage specification. We propose that the RA–Gata3 signaling pathway orchestrates a transcriptional network involving Pax6 , Six1 , and Sox2 to ensure proper epithelial patterning, branching morphogenesis, and choanae formation during early craniofacial development.

  • Open Access

    TMEM2-mediated hyaluronan turnover maintains articular cartilage homeostasis during osteoarthritis progression

    by Tomoya Murotani, Toshihiro Inubushi, Yu Usami, Taisei Tomohiro, Wu Deyang, Shinnosuke Kusano, Renshiro Kani, Shamma Hisham, Yuki Shiraishi, Hiroshi Kurosaka, et al.

    Osteoarthritis (OA) is a degenerative joint disease characterized by progressive disruption of the cartilage extracellular matrix (ECM), yet the molecular mechanisms governing ECM turnover during disease initiation remain incompletely defined. Hyaluronan (HA) is a major structural component of articular cartilage, and its regulated turnover is essential for maintaining tissue integrity. Transmembrane protein 2 (TMEM2) is a cell-surface hyaluronidase capable of degrading high–molecular weight HA under physiological conditions, but its role in joint tissues has remained unclear. Here, we examine the spatiotemporal expression and functional contribution of TMEM2 in articular cartilage using single-cell transcriptomic analysis, histological approaches, and a chondrocyte-specific conditional knockout mouse model. Under physiological conditions, Tmem2 was predominantly expressed in non-calcified articular chondrocytes. Following joint destabilization, Tmem2 expression was transiently increased during early osteoarthritis, coinciding with reduced cartilage HA content, consistent with altered HA turnover. Importantly, genetic ablation of Tmem2 in chondrocytes markedly exacerbated osteoarthritis progression, resulting in accelerated cartilage delamination, increased chondrocyte apoptosis, reduced proliferative activity, and enhanced hypertrophic differentiation. These changes occurred without detectable abnormalities in the synovium, subchondral bone, or osteophyte formation, indicating a cartilage-intrinsic phenotype. Collectively, these findings identify TMEM2 as an important regulator of hyaluronan homeostasis within the cartilage ECM and provide in vivo genetic evidence that TMEM2- dependent HA turnover contributes to the maintenance of articular cartilage integrity during osteoarthritis progression.

  • Open Access

    Expression analysis of genes including Zfhx4 in mice and zebrafish reveals a temporospatial conserved molecular basis underlying craniofacial development

    by Shujie Liu, Lin Xu, Makoto Kashima, Rika Narumi, Yoshifumi Takahata, Eriko Nakamura, Hirotoshi Shibuya, Masaru Tamura, Yuki Shida, Toshihiro Inubushi, et al.

    Background: Embryonic craniofacial development involves several cellular and molecular events that are evolutionarily conserved among vertebrates. Vertebrate models such as mice and zebrafish have been used to investigate the molecular and cellular etiologies underlying human craniofacial disorders, including orofacial clefts. However, the molecular mechanisms underlying embryonic development in these two species are unknown. Therefore, elucidating the shared mechanisms of craniofacial development between disease models is crucial to understanding the underlying mechanisms of phenotypes in individual species.Results: We selected mice and zebrafish as model organisms to compare various events during embryonic craniofacial development. We identified genes (Sox9, Zfhx3 and 4, Cjun, and Six1) exhibiting similar temporal expression patterns between these species through comprehensive and stage‐matched gene expression analyses. Expression analysis revealed similar gene expression in hypothetically corresponding tissues, such as the mice palate and zebrafish ethmoid plate. Furthermore, loss‐of‐function analysis of Zfhx4/zfhx4, a causative gene of human craniofacial anomalies including orofacial cleft, in both species resulted in deformed skeletal elements such as the palatine and ethmoid plate in mice and zebrafish, respectively.Conclusions: These results demonstrate that these disease models share common molecular mechanisms, highlighting their usefulness in modeling craniofacial defects in humans.


  • Compromised actin dynamics underlie the orofacial cleft in Baraitser-Winter Cerebrofrontofacial syndrome with a variant in ACTB

    by Takayuki Tsujimoto, Yushi Ou, Makoto Suzuki, Yuka Murata, Toshihiro Inubushi, Miho Nagata, Yasuki Ishihara, Ayumi Yonei, Yohei Miyashita, Yoshihiro Asano, et al.

    Craniofacial anomalies encompassing the orofacial cleft are associated with > 30% of systemic congenital malformations. Baraitser-Winter Cerebrofrontofacial syndrome (BWCFF) is a rare genetic disorder attributed to variants in the actin beta (ACTB) or actin gamma genes that are correlated with a range of craniofacial abnormalities, including cleft lip and/or palate. The underlying pathological mechanism of BWCFF remains elusive, and it is necessary to investigate the etiology of orofacial clefts in patients with BWCFF. In this study, we identified a missense variant (c.1043C > T: p.S348L) in the ACTB gene of a patient with BWCFF and concomitant cleft lip and palate. Furthermore, we performed functional assessments of this variant using various disease models such as the MDCK cell line and Xenopus laevis. These models revealed a compromised capacity of mutated ACTB to localize to the epithelial junction, consequently affecting the behavior of epithelial cells. Additionally, we discovered that the mutated ACTB exhibited an impaired ability to bind PROFILIN1, a critical factor in actin polymerization. This defective ability may contribute to the molecular etiology of aberrant epithelial cell adhesion and migration, resulting in orofacial cleft formation in BWCFF.


  • Treatment of anterior open bite in a patient with dentinogenesis imperfecta

    by Takayuki Tsujimoto, Hiroshi Kurosaka, Takashi Yamashiro

  • Open Access

    Characteristic craniofacial defects associated with a novel USP9X truncation mutation

    by Namiki Nagata, Hiroshi Kurosaka, Kotaro Higashi, Masaya Yamaguchi, Sayuri Yamamoto, Toshihiro Inubushi, Miho Nagata, Yasuki Ishihara, Ayumi Yonei, Yohei Miyashita, et al.

    Germline loss-of-function mutations in USP9X have been reported to cause a wide spectrum of congenital anomalies. Here, we report a Japanese girl with a novel heterozygous nonsense mutation in USP9X who exhibited intellectual disability with characteristic craniofacial abnormalities, including hypotelorism, brachycephaly, hypodontia, micrognathia, severe dental crowding, and an isolated submucous cleft palate. Our findings provide further evidence that disruptions in USP9X contribute to a broad range of congenital craniofacial abnormalities.


  • Open Access

    Compromised actin dynamics underlie the orofacial cleft in Baraitser-Winter Cerebrofrontofacial Syndrome with a variant in ACTB

    by Takayuki Tsujimoto, Yushi Ou, Makoto Suzuki, Yuka Murata, Toshihiro Inubushi, Miho Nagata, Yasuki Ishihara, Ayumi Yonei, Yohei Miyashita, Yoshihiro Asano, et al.

    Craniofacial anomalies encompassing the orofacial cleft are associated with >30% of systemic congenital malformations. Baraitser-Winter Cerebrofrontofacial syndrome (BWCFF) is a rare genetic disorder attributed to variants in the actin beta ( ACTB ) or actin gamma genes that are correlated with a range of craniofacial abnormalities, including cleft lip and/or palate. The underlying pathological mechanism of BWCFF remains elusive, and it is necessary to investigate the etiology of orofacial clefts in BWCFF. In this study, we identified a missense variant (c.1043C>T: p.S348L) in the ACTB gene from a patient with BWCFF and concomitant cleft lip and palate. Furthermore, we performed functional assessments of this variant using various disease models such as the MDCK cell line and Xenopus laevis . These models revealed a compromised capacity of mutated ACTB to localize at the epithelial junction, consequently affecting the behavior of epithelial cells. Additionally, we made the noteworthy discovery that mutated ACTB exhibited an impaired ability to bind PROFILIN1, a critical factor in actin polymerization. This defective ability may contribute to the molecular etiology of aberrant epithelial cell adhesion and migration, resulting in orofacial cleft formation in BWCFF. Author Summary: Advances in clinical sequencing have rapidly elucidated the genetic basis of rare diseases affecting multiple organs. In this study, we investigate the role of a variant in the ACTB gene, which is fundamental to cell structure, in causing orofacial clefts in the Baraitser-Winter Cerebrofrontofacial Syndrome (BWCFF), known for its distinctive facial anomalies. Using epithelial cell lines and frog embryo models, we investigated the effects of the ACTB gene alteration on cellular functions. Our results indicate that this genetic change disrupts the normal adhesion and movement of epithelial cells, processes that are critical for facial development. This research underscores the importance of the ACTB gene in shaping the face and suggests new directions for future research, potentially informing the diagnosis and treatment of BWCFF and related conditions.